Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)

ClinicalTrials.gov ID: NCT01642004

Public ClinicalTrials.gov record NCT01642004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Randomized Phase III Trial of BMS-936558 (Nivolumab) Versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to compare the overall survival of BMS-936558 as compared with Docetaxel in subjects with squamous cell non-small cell lung cancer (NSCLC), after failure of prior platinum-based chemotherapy.

Study identification

NCT ID
NCT01642004
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
272 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 15, 2012
Primary completion
Nov 16, 2014
Completion
Aug 15, 2021
Last update posted
Dec 27, 2022

2012 – 2021

United States locations

U.S. sites
39
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Mayo Clinic in Arizona - Scottsdale Scottsdale Arizona 85259
City Of Hope Duarte California 91010-3000
Local Institution - 0020 Duarte California 91010-3000
Local Institution - 0009 New Haven Connecticut 06520
Yale University New Haven Connecticut 06520
H. Lee Moffitt Cancer Center Tampa Florida 33612
Local Institution - 0004 Tampa Florida 33612
Local Institution - 0153 Marietta Georgia 30060
Local Institution - 0100 Chicago Illinois 60637
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21287
Local Institution - 0003 Baltimore Maryland 21287
Local Institution - 0036 Boston Massachusetts 02114
Local Institution - 0084 Boston Massachusetts 02114
Local Institution - 0150 Boston Massachusetts 02114
Local Institution - 0016 Mineola New York 11501
Winthrop University Hospital Mineola New York 11501
Columbia University Medical Center New York New York 10032
Local Institution - 0006 New York New York 10065
Memorial Sloan Kettering Nassau New York New York 10065
Duke University Medical Center Durham North Carolina 27710
Local Institution - 0008 Durham North Carolina 27710
Oncology Hematology Care, Inc. Cincinnati Ohio 45242
St Mary Medical Center Langhorne Pennsylvania 19047
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Local Institution - 0011 Philadelphia Pennsylvania 19111
Guthrie Medical Group, Pc Sayre Pennsylvania 18840
Local Institution - 0082 Columbia South Carolina 29210
Local Institution - 0087 Chattanooga Tennessee 37404
Local Institution - 0005 Nashville Tennessee 37203
Tennessee Oncology, PLLC Nashville Tennessee 37203
Local Institution - 0032 Nashville Tennessee 37232
Local Institution - 0012 Dallas Texas 75390
University Of Texas Southwestern Medical Center Dallas Texas 75390
Local Institution - 0086 Houston Texas 77030
Local Institution - 0017 Seattle Washington 98104
Swedish Cancer Institute Seattle Washington 98104
Local Institution - 0001 Seattle Washington 98109
University of Washington - Seattle Cancer Care Alliance Seattle Washington 98109
Local Institution - 0033 Morgantown West Virginia 26506-9162

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 88 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01642004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 27, 2022 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01642004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →